Novel therapeutic heterocycles as selective cyclooxygenase-2 inhibitors and anti-cancer agents: Synthesis, in vitro bioassay screenings, and molecular docking studies

Musa I. El‐Barghouthi, Ayman S. Hasan, Wajdy Al‐Awaida, Hamzeh J. Al‐Ameer, Jatinder Kaur, Kaita J. Hayashibara, Jeremy Fleming, Jessica Waknin, Shigeo Hayashibara, Muna Slewa, Samer M. Hamzeh, Khaled Bodoor, Joshua Daniel McLoud, Frank Wuest, Baker Jawabrah Al Hourani